NeuroSense Therapeutics Investor Presentation Deck
October 2024, 27 slides
  1. NeuroSense Therapeutics
  2. Related Decks
  3. Investor Presentation Decks
new hope on the horizon | NeuroSense Therapeutics
forward looking statements | NeuroSense Therapeutics
highlights | NeuroSense Therapeutics
focused pipeline go | NeuroSense Therapeutics
experienced leadership | NeuroSense Therapeutics
exceptional scientific advisory board | NeuroSense Therapeutics
als is a rapidly progressing fatal disease with a huge unmet need for new treatment options | NeuroSense Therapeutics
is targeting multiple key pathways in als | NeuroSense Therapeutics
synergistic mode of action boosts brain levels | NeuroSense Therapeutics
improves motor performance in als animal models | NeuroSense Therapeutics
improves neuronal survival in als human cell model | NeuroSense Therapeutics
phase a data demonstrated reduced and levels in als patients treated with | NeuroSense Therapeutics
paradigm phase trial design | NeuroSense Therapeutics
paradigm trial demonstrates safety and tolerability achieving primary | NeuroSense Therapeutics
improved disease progression by after months of treatment | NeuroSense Therapeutics
| NeuroSense Therapeutics
slowed functional decline across multiple domains with most pronounced effect on speaking and swallowing | NeuroSense Therapeutics
demonstrated positive trends across all secondary and exploratory including survival | NeuroSense Therapeutics
modulated and levels showing target engagement | NeuroSense Therapeutics
summary of paradigm phase results | NeuroSense Therapeutics
leading perceive paradigm results as highly compelling | NeuroSense Therapeutics
has strong commercial potential in als year | NeuroSense Therapeutics
road phase study design | NeuroSense Therapeutics
upcoming catalysts | NeuroSense Therapeutics
strong clinical and commercial potential | NeuroSense Therapeutics
inspired by als patients strongly supported by patient advocacy groups pea | NeuroSense Therapeutics
| NeuroSense Therapeutics
See More
NeuroSense Therapeutics
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Clinical trial
Recent decks by NeuroSense Therapeutics
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
See all presentations by NeuroSense Therapeutics (4 decks)
Related decks
Genprex
Investor Presentation
October 2022
argenx SE
Results
October 2022
Xeris Biopharma
Investor Presentation
October 2022
Genelux
Investor Presentation
February 2024
uBiome
Start Up
June 2017
Nuvalent
Investor Presentation
January 2024
Larimar Therapeutics
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
December 2023
Recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Genprex
Investor Presentation
October 2022
argenx SE
Results
October 2022
Xeris Biopharma
Investor Presentation
October 2022
Genelux
Investor Presentation
February 2024
uBiome
Start Up
June 2017
Nuvalent
Investor Presentation
January 2024
Larimar Therapeutics
Investor Presentation
November 2023
Immix Biopharma
Investor Presentation
December 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io